QTTB (STOCKS)
Q32 Bio Inc. Common Stock
$5.410000
+0.360000 (+7.13%)
Prev close: $5.050000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jodie P. Morrison
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $80.02M
- Employees
- 27
- P/E (TTM)
- 2.09
- P/B (TTM)
- 1.55
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $53.74M |
| Benefits Costs and Expenses | $23.92M |
| Costs And Expenses | $23.92M |
| Nonoperating Income/Loss | $12.92M |
| Operating Expenses | $36.84M |
| Research and Development | $19.16M |
| Other Operating Expenses | $17.68M |
| Operating Income/Loss | $16.90M |
| Income/Loss Before Equity Method Investments | $29.82M |
| Income/Loss From Continuing Operations After Tax | $29.82M |
| Income/Loss From Continuing Operations Before Tax | $29.82M |
| Income/Loss From Equity Method Investments | $0.00 |
| Income Tax Expense/Benefit | $0.00 |
| Interest Income/Expense After Provision For Losses | $1.06M |
| Interest Income/Expense Operating, Net | $1.06M |
| Net Income/Loss | $29.82M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $29.82M |
| Net Income/Loss Available To Common Stockholders, Basic | $29.82K |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $29.79M |
| Preferred Stock Dividends And Other Adjustments | $29.79M |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | $2.42 |
| Diluted Earnings Per Share | $2.42 |
| Basic Average Shares | 12,300,568 |
| Diluted Average Shares | 12,314,796 |
| Assets | $61.78M |
| Current Assets | $55.05M |
| Prepaid Expenses | $813.00K |
| Other Current Assets | $54.24M |
| Noncurrent Assets | $6.73M |
| Fixed Assets | $979.00K |
| Other Non-current Assets | $5.75M |
| Liabilities | $19.76M |
| Current Liabilities | $11.35M |
| Accounts Payable | $879.00K |
| Wages | $2.49M |
| Other Current Liabilities | $7.98M |
| Noncurrent Liabilities | $8.42M |
| Equity | $42.01M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $42.01M |
| Liabilities And Equity | $61.78M |
| Net Cash Flow From Operating Activities | -$33.54M |
| Net Cash Flow From Operating Activities, Continuing | -$33.54M |
| Net Cash Flow From Investing Activities | $7.00M |
| Net Cash Flow From Investing Activities, Continuing | $7.00M |
| Net Cash Flow From Financing Activities | -$3.13M |
| Net Cash Flow From Financing Activities, Continuing | -$3.13M |
| Net Cash Flow | -$29.67M |
| Net Cash Flow, Continuing | -$29.67M |
| Comprehensive Income/Loss | $29.82M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $29.82M |
| Other Comprehensive Income/Loss | $29.82M |
| Other Comprehensive Income/Loss Attributable To Parent | $0.00 |